SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-049933
Filing Date
2023-09-19
Accepted
2023-09-19 16:15:32
Documents
2
Period of Report
2023-09-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1648
2 POA DOCUMENT poa.txt EX-24 3839
  Complete submission text file 0001209191-23-049933.txt   6957
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Issuer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SUTRO BIOPHARMA, INC. 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Gerber Hans-Peter (Reporting) CIK: 0001992979 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38662 | Film No.: 231263929